The spectral fingerprints of a big drug company have once again been found all over academic publications. Documents released last week by a watchdog group based in Washington DC raise concerns about the role of writers paid by GlaxoSmithKline (GSK) in works attributed to psychiatric researchers at a number of US institutions.
A bold move by eight Pacific island nations to preserve the world's last large stocks of tuna is expected to face strong resistance at a meeting of the Western and Central Pacific Fisheries Commission (WCPFC) near Honolulu, Hawaii.
Animal activists last summer set fire to the alpine holiday home of Daniel Vasella, then chief executive of pharmaceutical giant Novartis of Basel, Switzerland, in one of relatively few violent attacks on scientists working with animals in German-speaking countries.
Luc Montagnier is applying unorthodox ideas to the treatment of autism. With support from the Autism Research Institute (ARI), based in San Diego, California, the Nobel laureate is about to launch a small clinical trial of prolonged antibiotic treatment in children with autism disorders.
Current unprecedented declines in biodiversity reduce the ability of ecological communities to provide many fundamental ecosystem services. Here we evaluate evidence that reduced biodiversity affects the transmission of infectious diseases of humans, other animals and plants. In principle, loss of biodiversity could either increase or decrease disease transmission.
To make tropical forests more resilient to climate change, we need a coordinated effort to refocus conservation tools at regional and international levels. (Correspondence)
